Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Ghko B 2026 Mar 11, 16:02

The Vanguard S&P 500 ETF is popular: Is VOO a good ETF to invest in?

Frances Wang 2026 Mar 11, 16:01

Forex Market Analysis: JPY/USD, CHF/USD, EUR/USD, GBP/USD

Ghko B 2026 Mar 11, 16:01

Most active stocks analysis: NVIDIA (NVDA), Tesla (TSLA), Amazon (AMZN) stock

Ghko B 2026 Mar 11, 16:01

A beginner's guide to investing in stocks: How to buy NVDA stock in United Arab Emirates?

Ghko B 2026 Mar 10, 16:02

DAX 30 technical outlook: What are the future predictions for the DAX?

Ghko B 2026 Mar 10, 16:01

Crypto Market Outlook 2026: BTC Eyes $100K–$200K, ETH Bullish Scenario, XRP Prediction

Frances Wang 2026 Mar 10, 16:01

Commodity market today: UAE gold prices swing, what factors affect the price of gold?

Ghko B 2026 Mar 10, 16:01

NIO stock surged 15% today: What’s happening with Nio Inc?

Ghko B 2026 Mar 10, 16:01

CFD Trading in France: Best CFD brokers and regulations explained, how CFD Trading works

Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Noah Lee 2025 Dec 06, 17:50

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee 2025 Dec 06, 17:00

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Liam James 2025 Dec 06, 12:40

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Ava Grace 2025 Dec 06, 11:50

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Noah Lee 2025 Dec 06, 10:50

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Emma Rose 2025 Dec 06, 09:40

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Ava Grace 2025 Dec 06, 09:30

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Sophia Claire 2025 Dec 06, 08:00

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift

Info

Spread

0.91

Spread (%)

0.6255 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

184425431040

Shares Outstanding

1241420528

Earnings Date (Next)

2013-01-28

Div Yield

2026-03-30

Ex-Dividend Date

2026-03-13

Forward annual dividend rate

3.28

Forward annual dividend yield

0.0221

EPS

6.77

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2026 Mar 02, 16:00

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B 2026 Mar 01, 16:00

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B 2026 Feb 26, 16:00

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Trustpilot